CD8 + cytotoxic T lymphocytes (CTLs) serve as central effectors in cancer immunotherapy by directly eliminating tumor cells. However, current clinical therapies face significant limitations. These ...
A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results